0001579618-15-000001.txt : 20150316 0001579618-15-000001.hdr.sgml : 20150316 20150316213043 ACCESSION NUMBER: 0001579618-15-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150312 FILED AS OF DATE: 20150316 DATE AS OF CHANGE: 20150316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARSHBANKS TRACY CENTRAL INDEX KEY: 0001579618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 15704715 MAIL ADDRESS: STREET 1: 1 SOUTH WACKER DRIVE STREET 2: SUITE 3900 CITY: CHICAGO STATE: IL ZIP: 60606 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-03-12 0 0001023024 ANI PHARMACEUTICALS INC ANIP 0001579618 MARSHBANKS TRACY 1 SOUTH WACKER DRIVE SUITE 3900 CHICAGO IL 60606 1 0 0 0 Common Stock 2015-03-12 4 S 0 143516 63 D 375829 I See Footnote 1 Common Stock 2015-03-12 4 S 0 5978 63 D 15656 I See Footnote 2 Common Stock 2015-03-12 4 S 0 58265 63 D 152579 I See Footnote 3 Common Stock 2015-03-12 4 S 0 2241 63 D 5870 I See Footnote 4 1: Held by: FA Private Equity Fund IV, L.P., of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1). 2: Held by: FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1). 3: Held by: The Productivity Fund IV Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1). 4: Held by: The Productivity Fund IV Advisors Fund Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1). Reporting person disclaims the existence of a "group" and disclaims beneficial ownership of any securities (except to the extent of such Reporting Person's pecuniary interest in such securities) other than any securities reported herein as being directly owned by such Reporting Person and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of any such securities for purpose of Section 26 or any other purpose. Tracy L. Marshbanks 2015-03-16